TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$19.99
−0.79%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $0.14
- Revenue estimate
- $7.3B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- $0.51
- EPS estimate
- $0.14
- Revenue actual
- $7.5B
- Revenue estimate
- $7.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +76.4%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $0.14 | $0.51 | Beat 251.72% | $7.5B |
| Jul 30, 2026 | $0.17 | $0.23 | Beat 33.21% | $7.7B |
| May 13, 2026 | $0.21 | $0.28 | Beat 33.33% | $6.9B |
| Jan 29, 2026 | $0.55 | $0.48 | Miss -12.73% | $7.7B |
| Oct 30, 2025 | $0.44 | $0.44 | In line | $7.4B |
| Jul 30, 2025 | $0.47 | $0.52 | Beat 10.64% | $7.6B |
| Jun 25, 2025 | — | -$0.22 | — | $7.2B |
| Jan 30, 2025 | $0.63 | $0.42 | Miss -33.33% | $7.3B |
| Oct 31, 2024 | $0.39 | $0.44 | Beat 12.82% | $7.9B |
| Jul 31, 2024 | $0.37 | $0.56 | Beat 51.35% | $7.5B |
| May 9, 2024 | $0.00 | -$0.01 | Miss -330.55% | $6.9B |
| Feb 1, 2024 | $0.10 | $0.51 | Beat 420.51% | $7.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 28, 2027